证券记录 · 已归档季度
RGEN
Repligen Corporation · Healthcare · Medical - Instruments & Supplies
17被追踪持有人
+1Δ持有人
26.68M持有股份
$3.32B报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +6.2% ·
股份流向 +2.5% ·
净新建仓位 +5.9%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 11.91K | $1.59M | n/a | n/a |
| Q2 2026 | 125 | +9 | 40.15M | $5.47B | +16 | −8 |
| Q1 2026 | 120 | -2 | 41.26M | $4.90B | +8 | −11 |
| Q4 2025 | 122 | -3 | 43.70M | $7.16B | +1 | −3 |
| Q3 2025 | 21 | +2 | 26.22M | $3.51B | +3 | −2 |
| Q2 2025 | 17 | +1 | 26.68M | $3.32B | +2 | −1 |
| Q1 2025 | 13 | +1 | 13.27M | $1.69B | +1 | n/a |
| Q4 2024 | 12 | 0 | 12.86M | $1.85B | +1 | −1 |
| Q3 2024 | 11 | -3 | 9.29M | $1.38B | n/a | −3 |
| Q2 2024 | 14 | n/a | 8.37M | $1.05B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 6.60M | -12.7% | $821.40M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 2 | BlackRock ✦ (被动) | 6.08M | n/a | $756.04M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 3 | The Vanguard Group ✦ (被动) | 5.08M | n/a | $631.50M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 4 | Point72 Asset Management ✦ | 1.91M | +71.4% | $237.96M | 0.6% | ▲ Add | 5 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (被动) | 1.62M | -3.9% | $201.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 1.61M | n/a | $200.66M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 7 | Citadel Advisors ✦ | 1.06M | -20.1% | $132.22M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 8 | Geode Capital Management ✦ (被动) | 980.74K | -1.1% | $122.00M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 9 | Millennium Management ✦ | 701.24K | +3424.3% | $87.22M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 313.14K | +39.0% | $38.95M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 11 | Norges Bank ✦ (被动) | 249.17K | +34.5% | $30.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Wellington Management ✦ | 143.50K | 新增 | $17.85M | 0.0% | New | 1 | SEC ↗ ×3 |
| 13 | PRIMECAP Management ✦ | 138.28K | +348.1% | $17.20M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Marshall Wace ✦ | 84.19K | -0.7% | $10.47M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 15 | Renaissance Technologies ✦ | 66.30K | 新增 | $8.25M | 0.0% | New | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 23.57K | +2.7% | $2.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 5.63K | +115.6% | $700,508 | 0.0% | ▲ Add | 3 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Wellington Management | $17.85M | 0.0% |
| Renaissance Technologies | $8.25M | 0.0% |
已清仓
| AQR Capital Management | $262,369 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 436 持有人, 65.14M 股份, $6.86B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 05
Loeillot Olivier
Officer, Director · 4.20K 股 · $798,380
Oct 05
Loeillot Olivier
Officer, Director · 1.33K 股 · $238,274
Sep 24
Loeillot Olivier
Officer, Director · 8.40K 股 · $1.60M
Sep 24
Loeillot Olivier
Officer, Director · 4.54K 股 · $862,980
Sep 21
Loeillot Olivier
Officer, Director · 5.43K 股 · $976,680
Sep 04
Loeillot Olivier
Officer, Director · 3.04K 股 · $503,506
Aug 20
Loeillot Olivier
Officer, Director · 5.43K 股 · $976,680
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Oct 07
SC 13G/A: FMR LLC
Aug 14
SC 13G/A: PRICE T ROWE ASSOCIATES INC /MD/
Jul 31
SC 13G: VANGUARD CAPITAL MANAGEMENT LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据